Min Thura

460 total citations
14 papers, 248 citations indexed

About

Min Thura is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Min Thura has authored 14 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Min Thura's work include Protein Tyrosine Phosphatases (4 papers), Peptidase Inhibition and Analysis (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Min Thura is often cited by papers focused on Protein Tyrosine Phosphatases (4 papers), Peptidase Inhibition and Analysis (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Min Thura collaborates with scholars based in Singapore, United States and Japan. Min Thura's co-authors include Qi Zeng, Kazuo Umemura, Kazuya Hokamura, Koichiro Wada, Naho Taniguchi, Yoshinori Muranaka, Ryota Nomura, Kazuhiko Nakano, Atsuo Amano and Atsushi Nakajima and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Min Thura

12 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Thura Singapore 6 98 78 66 55 44 14 248
Samir P. Bhagwat United States 11 56 0.6× 46 0.6× 196 3.0× 47 0.9× 133 3.0× 13 330
Joseph S. Ainscough United Kingdom 7 103 1.1× 18 0.2× 49 0.7× 30 0.5× 53 1.2× 8 355
Sangeetha Jayaraman United States 7 157 1.6× 10 0.1× 41 0.6× 10 0.2× 56 1.3× 12 320
Payal Chauhan India 10 34 0.3× 18 0.2× 102 1.5× 6 0.1× 40 0.9× 76 319
Ayşen Topalkara Türkiye 15 61 0.6× 9 0.1× 44 0.7× 219 4.0× 70 1.6× 32 660
Farzaneh Ghazavi Belgium 8 122 1.2× 4 0.1× 35 0.5× 38 0.7× 40 0.9× 12 258
Abbas Zamanian Iran 9 35 0.4× 14 0.2× 184 2.8× 30 0.5× 25 0.6× 34 356
Étienne Doré Canada 4 93 0.9× 8 0.1× 28 0.4× 10 0.2× 100 2.3× 6 246
Ana Caroline Costa-da-Silva Brazil 8 35 0.4× 5 0.1× 93 1.4× 138 2.5× 68 1.5× 13 288
Katarzyna Marcińska Poland 8 96 1.0× 132 1.7× 29 0.4× 37 0.7× 25 0.6× 15 387

Countries citing papers authored by Min Thura

Since Specialization
Citations

This map shows the geographic impact of Min Thura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Thura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Thura more than expected).

Fields of papers citing papers by Min Thura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Thura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Thura. The network helps show where Min Thura may publish in the future.

Co-authorship network of co-authors of Min Thura

This figure shows the co-authorship network connecting the top 25 collaborators of Min Thura. A scholar is included among the top collaborators of Min Thura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Thura. Min Thura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Thura, Min, Queenie Shu Woon Tan, Abhishek Gupta, et al.. (2025). PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases. Nature Communications. 16(1). 4791–4791.
2.
Park, Jae‐Hyun, Min Thura, Vi K. Chiu, et al.. (2025). The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy. Cell Reports Medicine. 6(5). 102120–102120. 1 indexed citations
3.
4.
Ye, Zu, Chee Ping Ng, Haidong Liu, et al.. (2024). PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity. Theranostics. 14(9). 3423–3438. 2 indexed citations
5.
Loh, Amos Hong Pheng, Min Thura, Abhishek Gupta, et al.. (2023). Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody. Molecular Therapy — Oncolytics. 30. 153–166. 1 indexed citations
6.
Thura, Min, et al.. (2023). PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types. Theranostics. 13(6). 1876–1891. 15 indexed citations
7.
Chee, Cheng Ean, Melissa Ooi, Soo Chin Lee, et al.. (2023). A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies. Targeted Oncology. 18(3). 391–402. 10 indexed citations
8.
Golanov, Eugene V., et al.. (2022). The Cholinergic Pathway and MitoK ATP Induce UCP4 Expression Involved in Neuroprotection of FN Stimulation in Rats. SHILAP Revista de lepidopterología. 2(6). e000362–e000362. 1 indexed citations
9.
Thura, Min, Zu Ye, Abdul Qader Al-Aidaroos, et al.. (2021). PRL3 induces polyploid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse. Communications Biology. 4(1). 923–923. 20 indexed citations
10.
Thura, Min, Joel Sng, Jie Li, et al.. (2021). Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs. Bioscience Reports. 41(9). 29 indexed citations
11.
Wang, Hao, Bin Liu, Abdul Qader Al-Aidaroos, et al.. (2015). Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans. Oncogene. 35(25). 3303–3313. 17 indexed citations
12.
Nakano, Kazuhiko, Kazuya Hokamura, Naho Taniguchi, et al.. (2011). The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nature Communications. 2(1). 485–485. 145 indexed citations
13.
Yamamoto, Seiji, Shinichiro Koizumi, Min Thura, Hayato Ihara, & Eugene V. Golanov. (2011). Electrical stimulation of cerebellar fastigial nucleus up-regulates uncoupling protein 4 and stabilizes mitochondrial membrane potential in the cortex. Neuroscience Research. 71. e406–e406. 3 indexed citations
14.
Thura, Min, Kazuya Hokamura, Seiji Yamamoto, et al.. (2009). GIF-0173 protects against cerebral infarction through DP1 receptor activation. Experimental Neurology. 219(2). 481–491. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samir P. Bhagwat Breakdown of academic impact, for papers by Joseph S. Ainscough Breakdown of academic impact, for papers by Sangeetha Jayaraman Breakdown of academic impact, for papers by Payal Chauhan Breakdown of academic impact, for papers by Ayşen Topalkara Breakdown of academic impact, for papers by Farzaneh Ghazavi Breakdown of academic impact, for papers by Abbas Zamanian Breakdown of academic impact, for papers by Étienne Doré Breakdown of academic impact, for papers by Ana Caroline Costa-da-Silva Breakdown of academic impact, for papers by Katarzyna Marcińska
Rankless by CCL
2026